These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Placebo response in refractory tardive akathisia. Remington G; Fornazzari L; Sethna R Can J Psychiatry; 1993 May; 38(4):248-50. PubMed ID: 8100184 [TBL] [Abstract][Full Text] [Related]
25. Relations between movement disorders and psychopathology under predominantly atypical antipsychotic treatment in adolescent patients with schizophrenia. Gebhardt S; Härtling F; Hanke M; Theisen FM; von Georgi R; Grant P; Mittendorf M; Martin M; Fleischhaker C; Schulz E; Remschmidt H Eur Child Adolesc Psychiatry; 2008 Feb; 17(1):44-53. PubMed ID: 17876506 [TBL] [Abstract][Full Text] [Related]
26. [Tardive dyskinesia induced by classical antipsychotic drugs: a Tunisian sample of schizophrenics]. Sejil I; Oumaya A; Bouguerra C; Mehdi F; Bellaaj R; Gallali S Encephale; 2013 May; 39 Suppl 1():S36-41. PubMed ID: 23219594 [TBL] [Abstract][Full Text] [Related]
27. Psychotic symptoms preceding ocular deviation in a patient with tardive oculogyric crises. Sachdev P; Tang WM Aust N Z J Psychiatry; 1992 Dec; 26(4):666-70. PubMed ID: 1362053 [TBL] [Abstract][Full Text] [Related]
28. Tardive dyskinesia in the mentally retarded: comparison of prevalence, risk factors and topography with a schizophrenic population. Cohen S; Khan A; Zheng Y; Chiles J Acta Psychiatr Scand; 1991 Mar; 83(3):234-7. PubMed ID: 1674398 [TBL] [Abstract][Full Text] [Related]
33. A placebo-controlled trial of selegiline (L-deprenyl) in the treatment of tardive dyskinesia. Goff DC; Renshaw PF; Sarid-Segal O; Dreyfuss DA; Amico ET; Ciraulo DA Biol Psychiatry; 1993 May; 33(10):700-6. PubMed ID: 8102552 [TBL] [Abstract][Full Text] [Related]
34. The influence of topography on the cognitive and psychopathological effects of tardive dyskinesia. Brown KW; White T Am J Psychiatry; 1992 Oct; 149(10):1385-9. PubMed ID: 1356314 [TBL] [Abstract][Full Text] [Related]
35. Acculturation is associated with the prevalence of tardive dyskinesia and akathisia in community-treated patients with schizophrenia. Sundram S; Lambert T; Piskulic D Acta Psychiatr Scand; 2008 Jun; 117(6):474-8. PubMed ID: 18479320 [TBL] [Abstract][Full Text] [Related]
36. Effects of clozapine on treatment-resistant akathisia and concomitant tardive dyskinesia. Wirshing WC; Phelan CK; van Putten T; Marder SR; Engel J J Clin Psychopharmacol; 1990 Oct; 10(5):371-3. PubMed ID: 1979566 [No Abstract] [Full Text] [Related]
37. Race and tardive dyskinesia among outpatients at a CMHC. Glazer WM; Morgenstern H; Doucette J Hosp Community Psychiatry; 1994 Jan; 45(1):38-42. PubMed ID: 7907310 [TBL] [Abstract][Full Text] [Related]
38. Withdrawal symptoms after long-term treatment with low-potency neuroleptics. Chouinard G; Bradwejn J; Annable L; Jones BD; Ross-Chouinard A J Clin Psychiatry; 1984 Dec; 45(12):500-2. PubMed ID: 6150030 [TBL] [Abstract][Full Text] [Related]